Government's Endorsement of Caldicott2 is a Landmark Milestone for Patient Privacy

FairWarningFairWarning Inc., the inventor and global leader in patient privacy monitoring, has welcomed the UK government's response to the Caldicott Review, describing its decision to accept all of the recommendations in the review as "a significant step towards transparent care and a landmark milestone for both patients and the NHS."

But the company says the announcement, which coincides with the publication of the Health & Social Care Information Centre's (HSCIC) guide to confidentiality in health and social care, is just the latest step in the long journey towards electronic healthcare - and has urged healthcare stakeholders to work collaboratively to drive a culture of privacy throughout the NHS and ensure that the Caldicott2 recommendations are fully implemented within 12 months.

The Caldicott report was first published in April 2013, following an independent review into how information about individuals is shared across the health and social care system. FairWarningwas highly supportive of the original recommendations and is therefore extremely encouraged by the government’s decision to endorse all of the review's proposals.

FairWarning shares the government's view that effective information sharing will not only lead to better health outcomes, but it will also improve care pathways and enhance the patient experience. The company wholly supports the finding that there is no contradiction between increasing data sharing for care and improving the safeguards for personal confidential data.

However, electronic healthcare can only succeed if patients feel in greater control of their personal confidential information and are confident that the NHS is ensuring that information is secure, protected and shared appropriately. As such, moves to harness the power of information must be underpinned by robust information governance and information risk management processes that protect patient confidentiality.

Tim Dunn, General Manager for FairWarning UK commented: "Tools to help NHS professionals provide transparency on who is accessing patient records, and enabling trusts to monitor access proactively, are readily available and being successfully deployed in parts of the UK. We welcome that, in its response to Calidicott2, the government has acknowledged the implementation of privacy breach monitoring in Scotland. We believe that the full implementation of these recommendations could bring the rest of the UK to the high standard levels achieved in NHS Scotland, and ensure information assurance for UK trusts."

FairWarning considers the government's guidelines an important framework to ensure transparency and accountability for patient privacy. However, the company also believes the NHS' ability to implement the recommendations will be pivotal to the expansion of trust in digital healthcare.

Tim Dunn concluded: "It is now critical that Dame Fiona’s recommendations are implemented in a timely fashion, in line with the deadlines set out in the Caldicott Review and the response of the Department of Health (DH). Jeremy Hunt’s ambitions for electronic healthcare rely on executing this plan and protecting patient privacy will be at the heart of those efforts.

"The development of electronic healthcare models will indeed require both a step change and a concerted effort at national and local level. The time to act is now and FairWarning looks forward to supporting the DH and its partners in achieving these important goals."

About Caldicott2
The independent Information Governance Review led by Dame Fiona Caldicott, entitled 'Information: to share or not to share?' and also known as Caldicott2, was set up in February 2012 and delivered its final report and recommendations in April 2013. The aim of the review was to advise on how to achieve a better balance between protecting and sharing confidential personal information. The review produced a set of 7 revised "Caldicott Principles" and 26 specific recommendations. Dame Fiona will now chair an independent panel to oversee and scrutinise implementation of the review's recommendations and to provide advice on information governance issues.

About FairWarning, Inc.
FairWarning empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex privacy laws. By partnering with FairWarning, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, and Canadian provincial healthcare privacy law.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...